Who owns DXCM
932 institutions reported holding DXCM for 2026Q1, together 92% of the company, more than the 906 a quarter earlier.
932
Institutions reporting a position · as of 2026Q1 · up from 906 the quarter before
- Shares held by institutions
- 361.4M
Shares held by institutions · 92% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $22.7B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 34%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 134
- Positions exited
- 115
- Added to
- 349
- Reduced
- 295
- Top 10 holdersof the company
- 45%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 932 | 361.4M | $22.7B |
| 2025Q4 | 906 | 364.2M | $25.7B |
| 2025Q3 | 892 | 362.4M | $24.4B |
| 2025Q2 | 921 | 364.1M | $31.7B |
| 2025Q1 | 913 | 362.6M | $24.7B |
| 2024Q4 | 930 | 357.1M | $27.8B |
| 2024Q3 | 873 | 357.3M | $24.0B |
| 2024Q2 | 987 | 372.5M | $42.2B |
| 2024Q1 | 1,013 | 367.5M | $50.9B |
| 2023Q4 | 959 | 377.2M | $46.7B |
| 2023Q3 | 888 | 366.7M | $34.2B |
| 2023Q2 | 933 | 367.8M | $47.2B |
| 2023Q1 | 885 | 367.8M | $42.7B |
| 2022Q4 | 902 | 368.9M | $41.8B |
| 2022Q3 | 781 | 366.0M | $29.6B |
| 2022Q2 | 782 | 369.7M | $27.6B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| VANGUARD GROUP INC | 48.2M | 12% | $3.03B |
| BlackRock Inc. | 39.0M | 9.9% | $2.45B |
| STATE STREET CORP | 17.9M | 4.6% | $1.13B |
| BAILLIE GIFFORD & CO | 15.6M | 4.0% | $980M |
| ALLIANCEBERNSTEIN L.P. | 12.9M | 3.3% | $858M |
| GEODE CAPITAL MANAGEMENT LLC | 12.3M | 3.1% | $773M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 9.7M | 2.5% | $612M |
| WELLINGTON MANAGEMENT GROUP LLP | 9.3M | 2.4% | $586M |
| Amundi Group | 6.3M | 1.6% | $398M |
| JPMORGAN CHASE & CO | 6.0M | 1.5% | $371M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Medical Devices
Ranks #12 of 35 by Smart Score